In an earnings call Wednesday, bluebird bio revealed it is unlikely to meet its first-quarter goal to submit a Biologics License Application for sickle cell disease (SCD) gene therapy lovo-cel.
Bluebird Faces Another Delay with BLA for Sickle Cell Gene Therapy Read More »
Históricamente, uno de los mayores misterios del protón ha venido siendo el origen de su masa. Resulta que la masa medida del protón no procede exclusivamente de sus componentes físicos, sus tres quarks conocidos como quarks de valencia. Dicho de otro modo, si se suman la …
En la última década, aprender inglés ha pasado de ser una exclusividad a ser una auténtica necesidad. Ser bilingüe en un idioma tan importante es una forma de asegurar un mejor futuro laboral, pero también se trata de una herramienta social muy impor …
Contacto Canadá es la mejor empresa para estudiar inglés Read More »
Noticias de la actualidad científica y tecnológica del 27 de marzo de 2023. …
European biotech AlgoTx, a clinical stage innovator in complex pain, announces that the U.S. Food and Drug Administration has cleared the Investigational New Drug Application for its Phase 2 first-in-class candidate ATX01 in the treatment of erythromelalgia.
Merck, known as MSD outside of the United States and Canada, will hold its first-quarter 2023 sales and earnings conference call with institutional investors and analysts at 9:00 a.m. ET on Thursday, April 27.
Merck to Hold First-Quarter 2023 Sales and Earnings Conference Call on April 27 Read More »
DXVX announces that its affiliated company Oxford Vacmedix has completed Phase 1a trial of cancer vaccine and plans to proceed Phase 1b trial of OVM-200.
On March 29, 2023, Zylox-Tonbridge Medical Technology Co., Ltd. released its annual financial results for 2022.
Hansa Biopharma AB “Hansa”, a pioneer in enzyme technology for rare immunological conditions, announced the release of the Annual Report 2022.
Bioretec Ltd, a pioneer in bioresorbable orthopedic implants, has announced receiving the market authorization of the U.S. Food and Drug Administration for its pioneering RemeOs™ trauma screw to be used for healing of bone fractures aligned with the clinical trial.
